Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling
Open Access
- 1 February 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (8) , 6622-6630
- https://doi.org/10.1074/jbc.m104957200
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Involvement of p38 Mitogen-activated Protein Kinase Signaling Pathway in Osteoclastogenesis Mediated by Receptor Activator of NF-κB Ligand (RANKL)Journal of Biological Chemistry, 2000
- RANKing the importance of measles virus in Paget’s diseaseJournal of Clinical Investigation, 2000
- THE IL-4 RECEPTOR: Signaling Mechanisms and Biologic FunctionsAnnual Review of Immunology, 1999
- Interleukin-4 Down-regulates Both Forms of Tumor Necrosis Factor Receptor and Receptor-mediated Apoptosis, NF-κB, AP-1, and c-Jun N-Terminal KinaseJournal of Biological Chemistry, 1998
- Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and ActivationCell, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 geneNature, 1996
- Role for interleukin‐4 in foreign‐body giant cell formation on a poly(etherurethane urea) in vivoJournal of Biomedical Materials Research, 1995
- Interleukin-4 as a potent inhibitor of bone resorptionBiochemical and Biophysical Research Communications, 1990